CymaBay Therapeutics Inc. (CBAY) Surged 5.1% or 0.48 To Price $9.9 On Thursday


CymaBay Therapeutics Inc. (CBAY) surged 5.1% or 0.48 to $9.9. It is nearly 857705 shares traded, which is 157.78% compare to the average total volume 543597. The market cap of CBAY is $434.25 million. The year to date change is 4.67%. The 52 week price range is from $1.46 to $9.9. Price of CBAY have changed 3.40% during last week. It have changed 10.95% over last month, 22.82% over last 3 months, 59.93% over last 6 months N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBAY is 8.64. It is -12.73% below current price. The 200-day Moving Averages for CBAY is 6.41. It is -35.25% below current price. The 52-week High is 9.9. The stock hits 52-week high today. The 52-week Low is 1.46. It is -85.25% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CBAY is 4.2 on 2017-12-15. Short % to float is 4.80%. There are some statistics of CBAY. It is has market cap $434.25 million. The share outstanding is 43.86 million. The average volume is 543597. The percent of top 15 Institution holding is 65.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBAY is -60.65%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBAY is -45.25%.


Tags:

Share this post